Concord Drugs Ltd.
| BSE: 538965 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE858L01010 |
| BSE 00:00 | 24 Apr | Concord Drugs Ltd |
| NSE 05:30 | 01 Jan | Concord Drugs Ltd |
| OPEN | 18.45 |
| PREVIOUS CLOSE | 18.45 |
| VOLUME | 2564 |
| 52-Week high | 23.15 |
| 52-Week low | 11.68 |
| P/E | 32.23 |
| Mkt Cap.(Rs cr) | 14 |
| Buy Price | 17.65 |
| Buy Qty | 15.00 |
| Sell Price | 18.99 |
| Sell Qty | 192.00 |
About Concord Drugs Ltd.
Concord Drugs Ltd
CONCORD DRUGS LIMITED is a public limited company established in 1995 is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals Dry powder ) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilitie...> More
Concord Drugs Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr)
|
14 | |
| EPS - TTM | () |
[*S] | 0.56 |
| P/E Ratio | (X) | [*S] | 32.23 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 28.58 |
| P/B Ratio | () |
[*S] | 0.63 |
Announcement
-
Un-Audited Financial Results For The Quarter Ended 31.12.2019
-
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31.12.2019
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
-
Statement Of Investor Complaints For The Quarter Ended December 2019
Concord Drugs Ltd - Financial Results
Particulars ( cr) |
Dec 2019 | Dec 2018 | % Chg |
| Net Sales | 10.91 | 9.21 | 18.46 |
| Other Income | 0.02 | 0.02 | 0 |
| Total Income | 10.93 | 9.23 | 18.42 |
| Total Expenses | 10.09 | 8.23 | 22.6 |
| Operating Profit | 0.83 | 1 | -17 |
| Net Profit | 0.04 | 0.04 | 0 |
| Equity Capital | 8.74 | 7.86 | - |
Concord Drugs Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| ANG Lifesciences | 37.50 | -3.85 | 19.42 |
| Parnax Lab | 20.09 | 1.01 | 17.08 |
| Ind-Swift | 2.75 | -3.51 | 14.89 |
| Concord Drugs | 18.05 | -2.17 | 14.19 |
| Transchem | 11.30 | -2.16 | 13.83 |
| Medi Caps | 10.98 | -4.94 | 13.69 |
| Sandu Pharma. | 19.00 | 0.96 | 13.45 |
Concord Drugs Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherConcord Drugs Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 1.63% | NA | -0.83% | -1.21% |
| 1 Month | 44.40% | NA | 17.44% | 17.35% |
| 3 Month | 6.24% | NA | -24.72% | -25.26% |
| 6 Month | 15.71% | NA | -19.72% | -20.96% |
| 1 Year | -17.95% | NA | -19.79% | -21.93% |
| 3 Year | -67.27% | NA | 5.64% | -0.69% |
Concord Drugs Ltd - STOCK STRENGTH
| Today's Low/High | 18.00 |
|
19.27 |
| Week Low/High | 16.45 |
|
19.00 |
| Month Low/High | 11.68 |
|
19.00 |
| YEAR Low/High | 11.68 |
|
23.00 |
| All TIME Low/High | 11.68 |
|
91.00 |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
